Atyr Pharma raises $76 mln
Atyr Pharma Inc. said Tuesday it raised $76 million in Series E financing led by new investor Sofinnova Ventures and an undisclosed large institutional investor in the biotechnology industry. Also taking part in the round were T. Rowe Price Associates Inc.; Federated Investors Inc.; Deerfield; Rock Springs Capital Management; EcoR1 Capital; Sphera Global Healthcare and two additional undisclosed institutional investors. Atyr said current venture capital investors and a current public investment fund took part in the raise as well. San Diego-based Atyr Phrama is a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address rare diseases.
1 April 2015•3 mins read
